Jeffrey Chodakewitz
CIK 1610876 · EVP GMDA, CMO · last filed 2025-06-27
Jeffrey Chodakewitz is an EVP GMDA, CMO who has filed 62 SEC Form 4 insider transactions across 7 companies since 2014. The most recent filing, for PRAX, was dated Jun 27, 2025. Across all open-market trades the lifetime net is −$30.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $32.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$32.60M
7
62
-$30.85M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRAX | Director | — | $266.58 | — | $0 | 5 | 2025-06-27 |
| SDGR | Director | 17,247 | $14.45 | $249.2K | $0 | 6 | 2025-06-20 |
| ACET | Director | 17,700 | $8.05 | $142.5K | $0 | 7 | 2025-06-13 |
| NCNA | Director | — | $1.95 | — | $0 | 1 | 2024-08-23 |
| Adicet Bio, Inc. (TORC) Delisted | Director | — | — | — | $0 | 3 | 2020-06-05 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Director | — | — | — | $0 | 5 | 2019-06-11 |
| VRTX | EVP GMDA, CMO | 72,385 | $444.93 | $32.21M | -$30.85M | 35 | 2018-02-14 |
Recent Filings
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-27 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | SDGR | Grant (A) | +5,997 | $0 | EDGAR |
| 2025-06-13 | ACET | Grant (A) | +5,900 | $0 | EDGAR |
| 2024-08-23 | NCNA | Mixed | — | $0 | EDGAR |
| 2024-06-20 | SDGR | Grant (A) | +5,000 | $0 | EDGAR |
| 2024-06-07 | ACET | Grant (A) | +5,900 | $0 | EDGAR |
| 2024-06-06 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2023-08-16 | ACET | Mixed | — | $0 | EDGAR |
| 2023-06-16 | SDGR | Grant (A) | +6,250 | $0 | EDGAR |
| 2023-06-14 | PRAX | Grant (A) | — | $0 | EDGAR |